Inactive Instrument
Abpro Corporation Stock Nasdaq
Stocks
US0008501076
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 2.08M 1.85M 1.73M 1.57M 2.97M 200M 2.99M 20.89M 8.09M 102M 7.81M 7.64M 328M | P/E 2024 |
-2.41x | P/E 2025 | -3.27x |
|---|---|---|---|---|---|
| Enterprise Value | 2.16M 1.92M 1.79M 1.63M 3.08M 208M 3.11M 21.69M 8.4M 106M 8.11M 7.94M 341M | EV / Sales 2024 |
497x | EV / Sales 2025 | - |
| Free-Float |
83.91% | Yield 2024 * |
-
| Yield 2025 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.08M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +20.19% | +81.44% | 57.39B | |
| +0.89% | -0.63% | +2.17% | +36.19% | 47.64B | |
| +0.36% | +0.81% | +342.39% | +742.40% | 44.29B | |
| -0.96% | -4.50% | +24.96% | +35.38% | 42.5B | |
| -0.20% | -0.77% | +4.13% | +105.50% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.33% | +22.72% | 28.53B | |
| +0.05% | -1.64% | -8.14% | -11.37% | 24.34B | |
| Average | -0.20% | -0.59% | +52.63% | +128.54% | 43.39B | |
| Weighted average by Cap. | +0.12% | -0.84% | +56.96% | +138.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 183K 163K 152K 138K 261K 17.59M 263K 1.84M 712K 8.99M 687K 672K 28.86M | - |
| Net income | -7.23M -6.43M -6M -5.47M -10.31M -695M -10.41M -72.58M -28.12M -355M -27.15M -26.56M -1.14B | -2.89M -2.57M -2.4M -2.19M -4.12M -278M -4.16M -29.02M -11.25M -142M -10.86M -10.62M -456M |
| Net Debt | 478K 425K 396K 361K 681K 45.95M 688K 4.8M 1.86M 23.49M 1.79M 1.76M 75.39M | 80K 71.08K 66.34K 60.47K 114K 7.69M 115K 803K 311K 3.93M 300K 294K 12.62M |
Employees
-
